All posts in In the Lab

  • Study shows TAK-733 may be be second-generation alternative for BRAF-mutant melanoma

    Next-Gen Melanoma Drug, TAK-733, Excels in Lab Tests

    A University of Colorado Cancer Center study published online this week in the journal Molecular Cancer Therapeutics reports anti-cancer activity in 10 out of 11 patient tumor samples grown in mice and treated with the experimental drug TAK-733, a small molecule inhibitor of MEK1/2.

brain coral
6783284175_e14925de8e_b
Child.Genetics.jpg
Sk@BIO USA 2012
Lichter.Pointing
3298849410_af0ef16e8d_b
alex's lemonade stand
CSUCarbonRadiotherapy.Cropped.jpg
Matches.jpg